- Home
- / Prime Medicine
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Prime Medicine financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$4.1
2024-10-29
Market Capitalization
$489.7 M
2024-10-29
Revenue
$4.6 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| Revenue | 3.0M | 4.6M | ||
| General and administrative expense | 29.8M | 43.4M | 50.2M | 52.3M |
| Operating expense total | 116.5M | 205.5M | 213.0M | |
| EBIT | (116.5M) | (204.8M) | (202.5M) | (208.3M) |
| EBIT margin, % | -6787.4% | -4498.1% | ||
| Interest income | 3.5M | 4.1M | ||
| Income tax expense | (948.0K) | (279.0K) | ||
| Net Income | (121.8M) | (198.1M) | (195.9M) | (201.1M) |
| EPS | (4.2) | (2.0) | (1.6) | (1.3) |